Igal Tarash, DO MD | |
11937 Us Highway 271, Tyler, TX 75708-3154 | |
(903) 877-7168 | |
(903) 877-8356 |
Full Name | Igal Tarash |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 11937 Us Highway 271, Tyler, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053818286 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | S6538 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Igal Tarash, DO MD 11937 Us Highway 271, Tyler, TX 75708-3154 Ph: (903) 877-7168 | Igal Tarash, DO MD 11937 Us Highway 271, Tyler, TX 75708-3154 Ph: (903) 877-7168 |
News Archive
Since the emergence in December 2019 in Wuhan, China, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide via transmission among close human contacts. Early on, several public health interventions were implemented in Wuhan city and Hubei Province, including lockdowns, social distancing, traffic restrictions, stay-at-home policies, face mask requirements, building temporary hospitals, and centralized quarantine. There were 50,355 confirmed cases of SARS-CoV-2 infection in Wuhan as of 28 January 2021.
A thought-provoking new study reports that the anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibodies elicited by natural infection may not be able to neutralize emerging strains that display deletion mutations in their genomic RNA.
Kansas leaders will include asymptomatic COVID-19 cases in their assessments of virus trends as they evaluate when to take further steps to ease stay-at-home orders and other social distancing measures.
ChemGenex Pharmaceuticals Ltd. Shares fell most in the last 16 years to AUD$0.44 following a concern raised by the US drug regulators – US FDA. The FDA requested on Monday for more uniform clinical test data before they review and consider approval of the company's new leukemia drug.
Pfizer Inc. presented today the results from a Phase 3 study demonstrating the immunogenicity, tolerability and safety of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine Diphtheria CRM197 Protein)in adults infected with human immunodeficiency virus (HIV).
› Verified 9 days ago
Brandon Riley, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 11937 Us Highway 271, Tyler, TX 75708 Phone: 903-877-7777 | |
Dr. Joseph Soliman Wassef, M.D., P.C. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2010 Sybil Ln Ste 150, Tyler, TX 75703 Phone: 903-504-5459 Fax: 903-504-5460 | |
Richard D Tyer, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 312 E 5th St, Tyler, TX 75701 Phone: 903-595-6789 Fax: 903-595-6973 | |
Dr. Yahyah Smadi, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 11937 Us Highway 271, Tyler, TX 75708 Phone: 903-877-7253 | |
Antoinette Lenton, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 520 Douglas Blvd, Tyler, TX 75702 Phone: 903-593-1721 | |
Dr. Robert Leon Boyne, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 700 Olympic Plaza Cir, Suite 912, Tyler, TX 75701 Phone: 903-596-3808 Fax: 903-596-3815 |